Sfoglia per AUTORE
CHON HJ
Collezione AOU Novara

  

Items : 3

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours. in Journal of hepatology / J Hepatol. 2024 Mar;80(3):431-442. doi: 10.1016/j.jhep.2023.10.040. Epub 2023 Nov 15.

2024
AOU Novara
AO Alessandria

Pinato DJ; Cammà C; Cortellini A; Pinto C; Bersanelli M; Brunetti L; Sorarù M; Montesarchio V; Bordi P; Cavanna L; De Giorgi U; Russo A; Laera L; Ricciardi S; Grossi F; Banzi M; Pipitone S; Bordonaro R; Negrini G; Di Pietro FR; Battelli N; Ficorella C; Zustovich F; Rossi E; Verderame F; Ermacora P; Antonuzzo L; Veccia A; Catino A; et alii...

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Nov;175:204-213. doi: 10.1016/j.ejca.2022.08.024. Epub 2022 Sep 20.

2022
AOU Novara

Cheon J; Fulgenzi CAM; D'Alessio A; Nishida N; Ang C; Marron TU; Wu L; Saeed A; Wietharn B; Cammarota A; Pressiani T; Personeni N; Pinter M; Scheiner B; Balcar L; Napolitano A; Huang YH; Phen S; Naqash AR; Vivaldi C; Salani F; Masi G; Bettinger D; Vogel A; Schönlein M; von Felden J; Schulze K; Wege H; Galle PR; et alii...

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis. in ESMO open / ESMO Open. 2022 Dec;7(6):100591. doi: 10.1016/j.esmoop.2022.100591. Epub 2022 Oct 6.

2022
AOU Novara

Rimini M; Rimassa L; Ueshima K; Burgio V; Shigeo S; Tada T; Suda G; Yoo C; Cheon J; Pinato DJ; Lonardi S; Scartozzi M; Iavarone M; Di Costanzo GG; Marra F; Soldà C; Tamburini E; Piscaglia F; Masi G; Cabibbo G; Foschi FG; Silletta M; Pressiani T; Nishida N; Iwamoto H; Sakamoto N; Ryoo BY; Chon HJ; Claudia F; et alii...